ICE vs PACB · P/E 37, rev $12.64B vs rev $38.4M
Intercontinental Exchange Inc (ICE) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. PACB currently screens at market cap $387.1M.
Not investment advice. Open the ICE and PACB stock pages for the full models.
Not investment advice.